Dr. Tod Mikuriya was a pioneering psychiatrist who spent his career researching and advocating for the medical use of cannabis. Through his work, Dr. Mikuriya treated over 9,000 patients with cannabis and maintained a list of more than 200 ailments
An MHRA license is required to manufacture Cannabis-based products for medicinal use (CBPMs) and active pharmaceutical ingredients (API). This license requires an inspection of the site to confirm it has an appropriate facility, staff and Pharmaceutical Quality Management System and has carried out the required activities (including process and analytical validation). There currently isn’t a way to operate both authorisation processes independently because each regulatory authorisation process requires some aspects of the other. Which presents a problem for new companies looking to enter the market. … Read More
If you’re new to the world of medical cannabis, CBD or industrial hemp, you may not have come across the term Good Manufacturing Practice (also known as GMP) before. It is a complicated regulatory landscape that cultivators and manufacturers of medical cannabis must understand if they are to meet compliance standards.
We’re here to shine a light on what exactly this means, why it’s important and what the benefits of GMP are. … Read More
Blockchain technology has dominated headlines for a number of years, and many industry leaders believe that blockchain is the future of business operations.
However, if you’re not familiar with the terminology, understanding exactly how this works can be a bit of a minefield. Luckily, the team at Ecoinomy have put together this useful guide of all things blockchain. … Read More
Blockchain technology has the potential to revolutionise many industries, and healthcare is no exception. With attractive features that include a secure and decentralized way to store and transfer data, blockchain has the ability to improve the efficiency, traceability and accuracy
What lies ahead for the European Cannabis Market in 2023? Carl Jat, CEO of Ecoinomy summarises & provides his thoughts in our latest article.
… Read More
New paper from our research team - several interesting findings that should be investigated in larger samples! https://twitter.com/Lindsay_Lo_/status/1638277237446266884
New paper examining differences in patterns of use and mental health in young adult vs older medical cannabis dispensary users! We found few differences btwn age groups. Reassuringly, younger individuals did not appear to have worse mental health related outcomes. Link ⏬
We are working on several innovative solutions that will change the future of medical cannabis & patient care.
✔️ A loyalty card for repeat organic medicines prescriptions
✔️ In-mobile app consultations
✔️ Supporting ongoing clinical trials
Find out more: https://www.ecoinomy.io/downloadwhitepaper/
Blockchain technology has the power to revolutionise how patients access medical cannabis. Here's an overview we've put together of exactly how this technology works 👇
https://www.ecoinomy.io/understanding-blockchain-technology/
The UK medical cannabis industry faces several challenges. One such example is the many barriers that many new businesses face when trying to secure an MHRA license, which is required to manufacture cannabis for medicinal use
The Ecoinomy healthcare blockchain ecosystem offers a suite of products and services for prescription organic medicine patients with the goal of powering research and healthcare innovation.
Patients will be able to allow companies and regulators to access to their medical data to improve clinical research whilst earning rewards in ECM for their participation.
